Core Viewpoint - A class action securities lawsuit has been filed against Semler Scientific, Inc. for alleged securities fraud affecting investors between March 10, 2021, and April 15, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit claims that Semler Scientific failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act, while discussing potential violations in hypothetical terms [3]. - Defendants' public statements are alleged to have been materially false and misleading throughout the relevant period [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until October 28, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the U.S. [5].

Core Insights - The article emphasizes the importance of understanding macro trends and their influence on asset prices and investor behavior, particularly in the context of equity analysis and research [1]. Group 1: Professional Background - The author has over 10 years of experience in asset management, focusing on equity analysis, macroeconomics, and risk-managed portfolio construction [1]. - The professional background includes advising on and implementing multi-asset strategies, with a strong emphasis on equities and derivatives [1]. Group 2: Investment Philosophy - The article advocates for making investing accessible, inspiring, and empowering, highlighting the value of sharing insights and building confidence in long-term investing [1]. - The author encourages readers to conduct their own research before making investment decisions, reinforcing the idea that the analysis provided is for informational purposes only [1].

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Semler (SMLR) To Contact Him Directly To Discuss Their Options If you purchased or acquired Semler Scientific securities between March 10, 2021 and April 15, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- What’s Happenin ...

Core Viewpoint - Semler Scientific Inc. is facing a securities fraud class action lawsuit due to alleged misleading statements and failure to disclose material facts regarding investigations by the U.S. Department of Justice [4][5]. Group 1: Lawsuit Details - The lawsuit is based on claims that Semler made materially false and misleading statements about its business and operations during the class period from March 10, 2021, to April 15, 2025 [4]. - The company disclosed a risk of a DOJ complaint related to its QuantaFlo device and acknowledged an initial civil investigative demand from the DOJ dating back to July 2017 [2][4]. - Following the announcement of a settlement agreement with the DOJ for $29.75 million, Semler's stock price fell significantly, indicating investor injury [3]. Group 2: Financial Impact - On March 3, 2025, Semler's stock price dropped by $4.03, or 9.4%, closing at $38.89 per share after the DOJ news [3]. - After the April 15, 2025 announcement regarding the settlement, the stock price fell by $3.40, or 9.9%, closing at $31.00 per share [3]. Group 3: Investor Participation - Investors who acquired Semler securities during the class period are urged to participate in the class action lawsuit, with a deadline set for October 28, 2025, to seek lead plaintiff status [5].

Core Viewpoint - Semler Scientific, Inc. is under investigation for potential claims related to a federal securities class action, with a deadline for investors to seek lead plaintiff status set for October 28, 2025 [1] Group 1 - Faruqi & Faruqi, LLP, a prominent national securities law firm, is leading the investigation into Semler Scientific [1] - The investigation pertains to potential claims against Semler Scientific, indicating possible legal challenges ahead for the company [1] - Investors are reminded of the deadline to participate in the class action, emphasizing the urgency for affected parties [1]

Core Insights - Strive Asset Management and Semler Scientific stocks experienced significant premarket gains, with Strive rising approximately 30% to $1.46 and Semler increasing 18% to $28.40, driven by the merger announcement of the two bitcoin treasury companies [1][3] Group 1: Stock Performance - Strive's shares surged about 30% to $1.46, while Semler's stock rose 18% to $28.40 in premarket trading [1] - The rally followed investor Mike Alfred's announcement of acquiring over 1 million shares of Strive [1] - The WallStreetBets community has shown increased interest in Strive, listing it among the top-trending tickers with over 100 mentions [2] Group 2: Merger Details - Strive announced an all-stock acquisition of Semler Scientific, valuing Semler at a 210% premium, or $90.52 per share based on the previous Friday's close [3] - Each Semler share will convert into 21.05 shares of Strive upon the deal's completion [3] Group 3: Market Reaction - Following the merger announcement, both stocks faced a decline, with ASST trading below $0.80 per share at one point, nearly 50% below the bitcoin value on its balance sheet [4] - The combination of low valuation, a rebound in bitcoin prices, and Alfred's tweet contributed to the recent stock price surge [4]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Click Holdings Limited (CLIK) is up 81% at $11.17 [3] - Avidity Biosciences, Inc. (RNA) is up 43% at $70.72 [3] - Dyne Therapeutics, Inc. (DYN) is up 37% at $23.58 [3] - Zenas BioPharma, Inc. (ZBIO) is up 21% at $29.00 [3] - ProPetro Holding Corp. (PUMP) is up 18% at $7.47 [3] - PepGen Inc. (PEPG) is up 17% at $5.35 [3] - Unusual Machines, Inc. (UMAC) is up 15% at $14.85 [3] - Semler Scientific, Inc. (SMLR) is up 14% at $27.32 [3] - ETHZilla Corporation (ETHZ) is up 13% at $20.51 [3] - Relmada Therapeutics, Inc. (RLMD) is up 13% at $2.38 [3] Premarket Losers - Smart Logistics Global Limited (SLGB) is down 37% at $3.21 [4] - MaxsMaking Inc. (MAMK) is down 22% at $4.08 [4] - Prenetics Global Limited (PRE) is down 14% at $14.40 [4] - United States Antimony Corporation (UAMY) is down 14% at $10.22 [4] - NeurAxis, Inc. (NRXS) is down 12% at $3.01 [4] - Obook Holdings Inc. (OWLS) is down 9% at $11.39 [4] - Qualigen Therapeutics, Inc. (QLGN) is down 9% at $3.30 [4] - Critical Metals Corp. (CRML) is down 8% at $13.70 [4] - Neuphoria Therapeutics Inc. (NEUP) is down 8% at $5.73 [4] - Beam Therapeutics Inc. (BEAM) is down 7% at $25.86 [4]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Semler Scientific, Inc. regarding a class action lawsuit due to alleged misleading statements and failure to disclose a material investigation by the U.S. Department of Justice [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from March 10, 2021, to April 15, 2025 [2]. - Allegations include that Semler Scientific did not disclose a material investigation by the U.S. Department of Justice related to violations of the False Claims Act [2]. - The deadline for shareholders to register for the class action is October 28, 2025 [3]. Group 2: Next Steps for Shareholders - Shareholders who register will be enrolled in a portfolio monitoring software to receive updates on the case [3]. - There is no cost or obligation for shareholders to participate in the case [3]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].

Core Viewpoint - Strive Inc. has experienced significant stock price increases, driven by its strategic pivot to Bitcoin asset management and growing retail investor interest [1][2][6]. Group 1: Company Overview - Strive Inc. was founded by Vivek Ramaswamy as an "anti-woke" and "anti-ESG" asset manager, aiming to counter the politicization of corporate America by major asset managers like BlackRock, State Street, and Vanguard [1]. - The company recently merged with Asset Entities Inc. and continues to trade under the ticker symbol ASST on NASDAQ [2]. Group 2: Bitcoin Strategy - Strive has shifted focus to becoming a Bitcoin-centric asset manager, acquiring Semler Scientific Inc. in an all-stock deal and adding over 5,000 Bitcoins to its treasury [2]. - The company now holds approximately 10,900 Bitcoins, valued at $1.26 billion, making it one of the largest Bitcoin treasuries [3]. Group 3: Financial Activities - Strive is raising $1.5 billion through private placement financing and exercising available warrants to fund its Bitcoin acquisitions [3]. - The stock faced a pullback after the company filed to register nearly 1.3 billion new shares, raising concerns about potential dilution among existing shareholders [4]. Group 4: Retail Investor Engagement - The stock's recent rally was influenced by independent investor Mike Alfred, who purchased 1 million shares and promoted Strive as a promising Bitcoin treasury company [5]. - Following Alfred's announcement, Strive became the second most trending stock on Reddit and fifth on Yahoo Finance, indicating increased retail interest [6].

Core Viewpoint - Rosen Law Firm is reminding purchasers of Semler Scientific, Inc. securities of an important lead plaintiff deadline in a securities class action lawsuit [1] Group 1: Class Action Details - The class action pertains to securities purchased between March 10, 2021, and April 15, 2025, with a lead plaintiff deadline set for October 28, 2025 [1][2] - Investors who purchased Semler Scientific securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4] - Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [4] Group 3: Case Allegations - The lawsuit alleges that Semler Scientific made materially false and misleading statements and failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act [5] - The lawsuit claims that these misleading statements resulted in investor damages when the true details became public [5]